Australia's EBR Systems falls after US FDA's risk assessment
09/09/2026 04:33
BUZZ-Australia's EBR Systems falls after US FDA's risk assessment ** Shares of Australia's EBR Systems EBR.AX fall as much as 5% to A$0.285, their biggest intraday pct drop since Sept 2
** Stock on track to snap four consecutive sessions of gains, if current trend holds
** The wireless cardiac pacing system provider says that the U.S. Food and Drug Administration (FDA) has categorized security incident as "Controlled Risk"
** In February, company became aware of a cybersecurity incident that led to unauthorized access of personal information, including others
** In response, company has implemented corporate
cybersecurity improvements and hardening activities to prevent future security risks
** YTD, stock down nearly 66%
(Reporting by Aamir Sheik Khalid in Bengaluru)
Recent news on EBR Systems
See all newsAustralia's EBR Systems jumps on filing application for heart treatment
Brief: EBR Systems Submits TGA ARTG Application For Wise® System
Australia's EBR Systems hits record low on weak third-quarter revenue outlook
Brief: EBR Systems Forecasts Q3 2026 Revenue Of US$2.4 MLN To US$2.5 MLN
Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026